Lapo Alinari
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma (NCT05755087) | Lapo Alinari | 2023-03-06 |
Track Lapo Alinari automatically
Every clearance here is in the API, with alerts when new ones post.